Lacosamid zur Monotherapie fokaler Epilepsien zugelassen
Crossref DOI link: https://doi.org/10.1007/s15202-017-1577-y
Published Online: 2017-02-06
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
